Cargando…
Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy
Although the incidence of hepatocellular carcinoma (HCC) occurring after hepatitis C virus (HCV) eradication has decreased, there are still reports of hepatocarcinogenesis. The present study investigated the histological changes of non-cancerous liver tissue obtained prior to interferon (IFN) therap...
Autores principales: | Kawaguchi, Toshihiro, Ide, Tatsuya, Kondo, Reiichiro, Nomura, Yoriko, Arinaga-Hino, Teruko, Kuwahara, Reiichiro, Amano, Keisuke, Sano, Tomoya, Akiba, Jun, Ohshima, Koichi, Yano, Hirohisa, Torimura, Takuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781808/ https://www.ncbi.nlm.nih.gov/pubmed/31616517 http://dx.doi.org/10.3892/etm.2019.8024 |
Ejemplares similares
-
Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after hepatitis C virus eradication
por: Kawaguchi, Toshihiro, et al.
Publicado: (2021) -
Tenofovir Alafenamide Rescues Renal Tubules in Patients with Chronic Hepatitis B
por: Sano, Tomoya, et al.
Publicado: (2021) -
Short-term efficacy after switching from adefovir dipivoxil and tenofovir disoproxil fumarate therapy to tenofovir alaferamide for chronic hepatitis B
por: Sano, Tomoya, et al.
Publicado: (2021) -
Growth differentiation factor 15 as a novel diagnostic and therapeutic marker for autoimmune hepatitis
por: Arinaga-Hino, Teruko, et al.
Publicado: (2022) -
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)